Search

everythinglearnresearchcommunity

for

Search:↓

Targeting Lgr5+ stem cells and Wnt signaling may effectively treat hair loss.

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

Sporadic trichoblastic neoplasms generally don't recur or spread, with one case showing a specific genetic fusion.

Marine-derived supplements may improve skin and hair health.

Tailored medication preparation and ongoing education are crucial for effective treatments.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Nutraceuticals help prevent diseases and improve health and skin.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

A 14-year-old girl with no menstrual period was diagnosed with Swyer Syndrome and treated for a related cancer risk.

COX-2 and Bcl-2 proteins are involved in Lichen Planus.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Follicle Stimulating Hormone is important for fertility.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Non-scarring hair loss can be diagnosed with two 4mm punch biopsies, one cut vertically and the other transversely.

RET mutation is important in familial medullary thyroid carcinoma, and BRAF mutation in papillary thyroid carcinoma is linked to more aggressive cancer and higher death rates.

Skin problems in the elderly are unique and may indicate other diseases, involving changes in skin, hair, nails, and increased cancer risk.

The document concludes that there have been significant improvements in diagnosing and treating skin diseases, including melanoma, with new techniques and therapies.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Hair loss is a common side effect of hormone treatments for cancer.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Dutasteride is approved to help manage prostate enlargement.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

The document emphasizes early detection and treatment of men's skin conditions and recommends protective measures and appropriate treatments for different age groups.

Finasteride significantly increases scalp hair and prevents hair loss in young and middle-aged men.

Psoriasis treatments range from topical creams to systemic medications with serious side effects, and while treatments can manage symptoms, there is no cure.

Zinc is effective for treating various skin conditions, including warts and acne.

New techniques have enhanced our understanding of how stem cells function and the role of mutations in aging tissues, which may influence future cancer therapies.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.